Abstract
Abstract 12769: Improving Performance of Technetium-99m Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis
Circulation (New York, N.Y.), v 140(Suppl_1 Suppl 1), A12769
19 Nov 2019
Abstract
IntroductionTechnetium-99m pyrophosphate (Tc PYP) scintigraphy is considered reliable for the non-invasive diagnosis of transthyretin cardiac amyloidosis (TTR-CA). Conventional planar uptake ratios (H/CL) may be confounded by blood pool/extra-cardiac isotope uptake reducing the diagnostic accuracy of planar imaging.HypothesisSingle-photon emission computed tomography-computed tomography (SPECT-CT) acquisition improves the performance of Tc PYP scintigraphy for TTR-CA.MethodsWe performed a retrospective analysis of all patients undergoing simultaneous Tc PYP planar and SPECT-CT scintigraphy for suspected TTR-CA at Mayo Clinic from 2014 to 2018 (n=749). At 3 hours, a planar H/CL value > 1.3 was considered positive (POS) and ≤ 1.3 was negative (NEG). SPECT-CT images were assessed for myocardial uptake by visual inspection and coded POS or NEG. Clinical data were categorized by planar/SPECT-CT concordance. Planar POS but SPECT-CT NEG patients were compared to planar POS and SPECT-CT POS patients.ResultsSee Table. A total of 381 patients were NEG by both planar and SPECT-CT, while 351 patients were POS by planar imaging. Of these planar POS patients, 46 (13.1%) were SPECT-CT NEG and 305 were SPECT-CT POS. Compared to patients POS by both modalities, planar POS SPECT-CT NEG patients had lower H/CL values, were more commonly female, and had received higher Tc PYP doses. Further, they had lower NTproBNP and Troponin T levels, and less severe perturbations in cardiac structure and function on echocardiography. Additionally, 17 patients were POS by SPECT-CT but not by planar imaging (data not shown), of which, 3 patients had an endomyocardial biopsy all of which were positive for ATTR on tissue mass spectrometry.ConclusionsPatients with POS planar but NEG SPECT-CT Tc PYP have a distinct phenotype which suggests the absence of TTR-CA. These data support combined use of planar and SPECT-CT-based methods for diagnosis of TTR-CA.
Metrics
1 Record Views
Details
- Title
- Abstract 12769: Improving Performance of Technetium-99m Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis
- Creators
- Daniel Davies - Mayo ClinicJohn Wells Askew - Mayo ClinicJoanne Benson - Mayo ClinicPanithaya Chareonthaitawee - Mayo ClinicGeoffrey Johnson - Mayo ClinicRobert Glynn - Mayo ClinicEli Muchtar - Mayo ClinicAngela Dispenzieri - Mayo ClinicMorie Gertz - Mayo ClinicMartha Grogan - Mayo ClinicMargaret Redfield - Mayo ClinicOmar AbouEzzeddine - Mayo Clinic
- Publication Details
- Circulation (New York, N.Y.), v 140(Suppl_1 Suppl 1), A12769
- Publisher
- American College of Cardiology
- Resource Type
- Abstract
- Language
- English
- Academic Unit
- General Internal Medicine
- Other Identifier
- 991022195048304721